DETECT - From Awareness to Action: Driving Multidisciplinary Application of Screening and Disease Modifying Therapies in Early Stage T1D
Podcast #1: Extending Childhood: A Caregiver's Story on Delaying T1D Progression
Pre-Test
Questions marked with a
*
are required
100%
Contact Information
First Name
Last Name
Email Address
A 16-year-old female tests positive for 3 islet autoantibodies upon screening. Her fasting blood glucose is 120 mg/dL and her HbA
1C
is 6.0%. She reports no symptoms of T1D and is up to date on vaccinations. What would you recommend as the most appropriate next step?
Wearable continuous glucose monitoring (CGM) device
Treatment with teplizumab
A low carbohydrate diet
None of the above
A 10-year-old male is admitted into the hospital after seeking emergency care for symptoms of diabetic ketoacidosis. He is diagnosed with Stage 3 T1D and has begun treatment with insulin. What would you recommend as the most appropriate next step?
Wearable CGM device
Treatment with teplizumab
A low carbohydrate diet
None of the above
Which of the following is NOT required for teplizumab infusions?
Premedicate with an antihistamine, an antiemetic and an NSAID/acetaminophen for the first 5 days
Monitor liver enzymes for signs of cytokine release syndrome
Insert a PICC line for infusion administered in patients between 8 and 15 years of age
Ensure infusions can be administered for 14 consecutive days
Done
Powered by
QuestionPro
Loading...
close
drag_indicator
close
Yes
Cancel
Continue
Answer Question
Continue Without Answering
Keep Data
Discard
close
drag_indicator
Custom Title
highlight_off